Ophthalmology Times - Ophthalmology news, articles, and events
By David Hutton. October 18th 2024. According to the company, there are no FDA-approved pharmacological therapies for age-related cataracts. Its C-KAD eye drop, improves vision in patients with early-to-moderate cataracts, by penetrating the eye to reduce lens clouding, the main cause for cataracts.
Physicians sort out pros and cons of several new IOLs on the market
Nov 12, 2021 · The 2 newest multifocal IOLs—AcrySof IQ PanOptix (Alcon) and Tecnis Synergy (Johnson + Johnson Vision)—almost guarantee a broader range of vision than EDoF IOLs but not the avoidance of photic phenomena, Sood said. The PanOptix is a trifocal lens with negative spherical aberration on its anterior surface that has diffractive rings in the ...
Alcon reveals final data from Vivity Registry Study which …
Sep 13, 2023 · Alcon has announced final data from its Vivity Registry Study, which monitored real-world patient experiences for up to 12 months post cataract surgery with implantation of either AcrySof IQ Vivity or AcrySof IQ Vivity Toric presbyopia-correcting intraocular lens (PCIOL).
Study suggests potential link between semaglutide and risk of non ...
Jul 9, 2024 · Boston researchers led by first author Jimena Tatiana Hathaway, MD, MPH, reported that there is a potential risk of the development of non-arteritic ischemic optic neuropathy (NAION) 1 associated with prescriptions for semaglutide (Wegovy, Ozempic, Novo Nordisk). Prescriptions with semaglutide are FDA approved to treat obesity and type 2 diabetes, respectively.
Myths and misconceptions about autologous serum for dry eye
Jun 22, 2020 · Special to Ophthalmology Times® Autologous serum eye drops (ASEDs) have become a mainstay of therapy for certain categories of patients with dry eye and those with underlying immunologic disease or poor epithelial healing.. The logistics of prescribing ASEDs have changed dramatically in the past few years, making their use far more convenient for patients and physicians alike.
Ophthalmologists: Castor oil shouldn’t be rubbed in the eyes, no …
Aug 8, 2023 · Ophthalmologists are issuing a warning not to use castor oil as a way to treat vision problems amid claims circulating on TikTok. In its heyday, castor oil was considered a jack-of-all-trades home remedy, used as a laxative, a moisturizer and even as a chest rub to ease lung congestion. Now, it is making a comeback as some influencers on TikTok ...
Long-term effects of COVID-19 on the ocular surface
Aug 16, 2024 · A team of Turkish investigators lead by Oğuzhan Kılıçarslan, FEBO, FICO, MD, reported that COVID-19 affected thecorneal endothelial cell morphology in patients with ocular symptoms. 1 Kılıçarslan is from the Department of Ophthalmology, Ayancık State Hospital, Sinop, Turkey. They conducted a study in which they investigated the long-term effects of the virus on corneal endothelial cell ...
2021 Best Program results: Wilmer Eye Institute grabs top spot
Nov 12, 2021 · The year 2021 saw the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, snaring the top spot in the Overall Best Program category.. The Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine, Miami, and Massachusetts Eye and Ear, Harvard Medical School, Harvard University, Boston, earned the second and third spots, respectively.
FDA approves pilocarpine hydrochloride ophthalmic solution for ...
Oct 18, 2023 · Orasis Pharmaceuticals announced the FDA has approved pilocarpine hydrochloride ophthalmic solution 0.4% (Qlosi) for the treatment of presbyopia in adults. The company announced it expects to have pilocarpine hydrochloride ophthalmic solution commercially available in the U.S. in the first half of 2024 …
Breaking down the dorzolamide shortage - Ophthalmology Times
Aug 9, 2019 · Essentially, brimonidine 0.1% (Alphagan P, Allergan) is often a reasonable substitution for dorzolamide, while brimonidine-timolol (Combigan, Allergan) is an ideal substitution for dorzolamide-timolol shortages, assuming no brimonidine allergy. Certainly, the dorzolamide shortage has helped us view branded pharmaceutical companies in a positive ...